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PCOS Project  
ABSTRACT 
Polycystic Ovarian Syndrome: Proposal for an Evidence-based Management Plan for an 
Electronic Patient Record System 
Mary Elizabeth DuRant 
 The goal of this change project was to improve the diagnosis and management of women 
with polycystic ovarian syndrome (PCOS) through the use of an electronic patient record system. 
PCOS is one of the top ten missed or delayed diagnoses as well as an inconsistently or 
mismanaged women’s health issue in primary care.  
 The chronic care model, known pathophysiology, and evidence-based research composed 
the framework used in developing the diagnosis and management plan for an electronic record 
system in a free health care clinic.  
The project was evaluated based on the following four objectives: 1. To provide an 
educational session at a free clinic to increase providers’ knowledge about diagnosing PCOS; 2. 
To assess health care providers' knowledge about PCOS and its management before and after an 
educational session; 3. To develop a management plan and imbed the plan in an electronic 
patient record system at the free clinic to improve efficiency and quality of care for PCOS 
management; 4. To evaluate the effectiveness of an electronic management plan in increasing the 
frequency of diagnosis and appropriateness of treatment of PCOS at the free clinic. Objective 
one was evaluated by testing providers’ knowledge before and after the educational session. Pre- 
and post educational session chart review was used to evaluate objectives two through four. 
Thirty- four total charts met the inclusion criteria for evaluation for this project. 
Analysis of the data revealed a significant improvement in knowledge level of providers 
after the educational session. However, no statistically significant difference between pre and 
post educational session was found in diagnosing and managing the metabolic status of the 
PCOS population at the clinic. 
This project is an initial step in utilizing technology to improve diagnosis and 
management of a frequently misdiagnosed or under diagnosed and mismanaged common chronic 
syndrome on women. 
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Polycystic Ovarian Syndrome: Proposal for an Evidence-based Management Plan for an 
Electronic Patient Record System 
Background and Significance  
Polycystic ovarian syndrome (PCOS), the most common endocrine disease of women of 
reproductive age, affects 5 % to 10% of women, causing lifelong ramifications which affect 
women‟s health (Dunaif, Givens, Haseltine, & Merriam, 1992; Hart, Hickey, & Franks, 2004). 
Despite PCOS being a common health problem in women, it is frequently under diagnosed and 
inconsistently managed (Tomlinson, & Pinkney, 2007). It is one of the top ten missed diagnoses 
in primary care. Multiple reasons contribute to this syndrome being difficult to diagnose during 
its early manifestation. The leading factors that contribute to missing a diagnosis by a provider 
include: failures in judgment (79%); vigilance or memory (59%); knowledge deficit (48%); and 
patient-related factors (46%) such as atypical clinical presentation (15%), and complicated 
medical history (10%) (Gandhi, et al., 2006). 
  In the case of PCOS, many reasons contribute an initial missed diagnosis by the health 
care provider. PCOS is a group of symptoms, signs, and biochemical features that occur in 
various combinations and with varying degrees of severity (Elghblawi, 2007). The predominant 
symptoms of PCOS, such as hirsutism and irregular or absent menstrual cycles, can be present 
due to other causes. The heterogeneous nature of this endocrine disorder causes women to 
present to various health care settings for help. With resolution of the problem, the patient may 
not return for further evaluation to determine the underlying cause of the initial problem. The 
inconsistencies in the investigation and management of PCOS compound this problem of failure 
to diagnose. 
                                                                                                                          PCOS Project 2 
PCOS is a chronic endocrine disorder that has a major impact on the reproductive, 
metabolic, and cardiovascular health of affected women.  Women with PCOS are at risk for 
developing type 2 diabetes mellitus, hyperlipidemia, endometrial cancer, and infertility problems 
(Ehrmann, 2005; Guzick, 2004; Sherif, 2006; Taylor, 1998). Providers in a free clinic in a West 
Virginia (WV) community which serves uninsured lower income people treat a population of 
women from 18 to 65 years of age. This clinic is the only access to primary health care these 
patients. The clinic is staffed by a variety of physicians and advanced practice nurse practitioners 
who volunteer their time or receive a small compensation for their services. Thus, providers from 
various specialties staff this clinic. It is therefore essential to educate primary care providers from 
differing health care specialties, nurses and other health care professionals about the criteria used 
to establish a diagnosis of PCOS in female patients. These practitioners must learn to initiate a 
management plan to prevent or minimize the complications and consequences of the disease.  
Scope of the Problem Related to PCOS; Necessary Knowledge Base for Health Care Providers 
 PCOS is a complex syndrome that does not present with a consistent set of symptoms. 
The sum of the whole syndrome causes greater morbidity than the complications from each 
individual symptom.  The genetic component and the presentation of menstrual irregularities in 
adolescence may cause both the adolescent and the health care provider to assume these 
symptoms are normal because they have occurred in other women in the family and irregular 
menses is common in early puberty (Meisler, 2002).  
Ideally, the diagnosis of PCOS should be suspected in childhood, and suspected if other 
women in the family have PCOS or have obesity with type 2 diabetes mellitus. Irregular 
menstrual cycles may be the first presenting symptom to suggest the existence of PCOS. Care in 
pediatrics, family medicine, or gynecology is often sought initially for help in regulating 
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menstrual cycles or in early adulthood to treat infertility. Oligo-ovulation manifests as menstrual 
irregularity and occurs in 70% of women with PCOS. Women with PCOS often report irregular 
menstrual patterns, and experience varying degrees of ovulatory dysfunction. Often the 
menstrual pattern (i.e., three to five days of menstrual flow every 28 to 35 days) occurs for the 
first one to two years after menarche (which occurs at the normal age), but menses then become 
less frequent, occurring every 45 to 365 days (Richardson, 2003). After the onset of puberty, 
75% of women with secondary amenorrhea meet the diagnostic criteria for PCOS (Azziz, et al, 
2006; Hill, 2003; King, 2007). This is why the diagnosis tends to be made post-puberty.  
Women enter the health care system seeking care for the individual symptoms causing a 
problem. Because there is a wide range of problems which result from PCOS, young teens and 
women enter the health care system seeking care from practitioners from many health care 
disciplines. Women often seek the care of the practitioner who they feel is appropriate to manage 
the immediate problem. Thus the immediate diagnosis, such as irregular menses, diabetes, or 
acne may be treated, but the diagnosis of PCOS may be delayed (Birnbaum, 2003).  
Hyperandrogenemia is present in 60% to 80% of women with PCOS (Azziz, et al, 2006). 
Elevated androgens cause hirsutism in 60% of sufferers, acne in 15% to 25%, and androgenic 
alopecia in an estimated 5% of women with PCOS (Azziz, et al.). The diagnosis may be made 
when women begin seeking help with dermatological or hair removal problems (Salmi, Zisser, & 
Jovanovic, 2004).  
Qualitative studies report phenotypic characteristics of PCOS affect quality of life and 
self esteem for these women. In Snyder‟s study (2006), women with PCOS recognized 
themselves as different from other women without the disease, as the syndrome manifests with 
varying symptoms. Higher than average weight gain, lack of regular menstrual cycles, very 
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heavy or continuous bleeding with occasional menses, growth of excessive unwanted facial and 
body hair, and severe mood swings were identified as the characteristics that made PCOS 
sufferers feel different. Patients with PCOS also expressed that feeling different created a sense 
of insecurity and isolation (Snyder). Obesity also contributed to a sense of being not normal or 
not looking like the media portrayal of femininity (Snyder). Women with PCOS identify that 
being a normal female means looking more female (without hirsutism), having a beautiful 
complexion, and having regular menstrual cycles (Snyder). They recognized that hirsutism and 
infertility problems made them feel less feminine as though womanhood had been stolen 
(Kitzinger & Wilmot, 2002; Snyder). The physical signs of PCOS can be detrimental to a teenage 
girl‟s self-image. Early diagnosis and treatment in adolescents are essential in ensuring health in 
adulthood and restoring self-esteem (Salmi, et al., 2004). 
The health care system does not have a niche into which PCOS fits. An e-mail 
correspondence with the medical director of the Center of Excellence in Women‟s Health 
(CoEWH) at a large eastern health science center also supports the patient perceived need for this 
project. The e-mail is as follows, “One of my patients recently pointed out that it is a disease 
without a home after she had been put off by several providers who did not feel competent to 
address it.” (Davisson, personal communication, March 19, 2008). In personal discussions with 
this author, three young women under 22 years of age stated that in their experiences, none of 
their health care providers had ever explained what PCOS is or the range of potential health 
problems it causes, nor did these providers discuss how PCOS could affect their lives.  
Diagnosing and Treating Chronic Illness 
Almost half the population of Americans, 133 million people, lives with a chronic 
condition (Partnership for Solutions, 2004). A chronic health care condition is any condition that 
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requires management by the affected person and interface with a health care system.  For the best 
outcome for patients suffering with a chronic disease, the management plan should involve both 
the provider and the patient in actively managing the disease (Wagner, Austin, & Von Korff, 
1996a, 1996b). PCOS is a chronic health care condition that should be managed daily by the 
patient with support from health care providers.  The management plan needs to focus on 
obtaining and maintaining an optimum state of health (Wagner, et al., 1996a)   
Traditional primary care systems are not designed to meet all the needs of a patient with a 
chronic illness. Problems in a traditional primary care system affecting the quality of care for 
patients with chronic illness include: 1) rushed practitioners either not aware or not following 
established care guidelines, 2) lack of care coordination due to the number of providers working 
in a given care site, 3) lack of active patient follow-up, and 4) patients not appropriately trained 
to manage their illness at home (Wagner, et al., 1996a, 1996b).  
Many primary care systems focus on treating episodic or acute occurrences of illness. 
The system, itself, reacts to delivering the care being requested by an ill person seeking care. The 
free health care clinic in WV in which this project is based operates in this reactive mode. One 
reason this occurs is because the clinic is staffed by clinicians who donate small amounts of their 
time. Only mid-level providers staff the clinic full time. With this pattern of staffing, continuity 
and coordination of care are often compromised. Patient‟s return or follow-up visits are often 
with a different provider than was the initial visit. These factors tend to support a traditional 
reactive approach to care. While PCOS is a common endocrine disorder in women, it is not one 
of the problems commonly expected to present to primary care clinics. This fact and the varied 
expertise of health care providers in the clinic may contribute to initially missing the diagnosis of 
PCOS and less than ideal care being initiated (Gandhi, et al., 2006). 
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In a systematic review of the literature, Azziz, et al. (2005) estimated approximately 4 
million women in the United States (U.S.) have PCOS. When comparing percentages of women 
with PCOS by region of the country, the greatest percentage, 34.72%, live in the Southern region 
of the U. S., which includes West Virginia (Health Care and Utilization [HCUP], 2005).  The 
2005 census reports 352,442 women of reproductive age, between the ages of 18 and 44, are 
living in W.V. (U.S. Census Bureau, 2006). Because 5% to 10% of women of reproductive age 
suffer from PCOS, one can estimate that 17,622 to 35,244 women in this state are living with 
PCOS.   
Theoretical Framework 
In an effort to address the health problems encountered in traditional primary care, 
Wagner (1998) developed a Chronic Care Model (CCM). This model focuses on primary health 
care system changes that are better able to manage patients with chronic conditions (Wagner). 
These system changes include a nontraditional care approach for the provider, staff, and patient. 
Studies reporting improvement in outcomes for various chronic illnesses support the 
choice to use CCM to guide the development of this project. Bodenheimer, Wagner, and 
Grumbach (2002a) performed a systematic review of studies of diabetes care programs that 
included the CCM. They used the studies completed by the Cochrane review of ambulatory care 
diabetic management programs as the basis for their review. The evidence demonstrates that the 
CCM can improve the management of chronic conditions and reduce health care costs. Thirty-
two of 39 studies found that interventions based on successful management of chronic illnesses 
are CCM model components that improved at least one process or outcome measure such as 
hemoglobin A1C for diabetic patients. Eighteen of 27 studies discussing congestive heart failure, 
asthma, and diabetes demonstrated reduced costs or lower use of health care services to manage 
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disease (Bodenheimer, et al., 2002a). A study that exemplifies the effective use of CCM is a 
randomized control trial performed in Denmark that focuses on primary care disease 
management for diabetics (Zoffman, Harder, & Kirkevold, 2008). Patients were randomized to a 
usual care group, or to an intervention group that provided decision support, regular follow-up, 
reminder systems, and self-management support based on individualized goals. After six years, 
the intervention group had significantly lower hemoglobin A1C, blood pressure and cholesterol 
levels. This outcome supports the premise that use of the CCM is effective in primary care for 
managing patients with chronic diseases. Other studies adopting CCM as the approach to treat 
chronic illnesses such as cardiovascular disease, congestive heart failure, chronic obstructive 
pulmonary disease, and depression report better patient outcomes than traditional models 
(Adams, et al., 2007; Feifer, Ornstein, Nietert, & Jenkins, 2001; Stroebel, et al., 2005). A pilot 
study by Stroebel et al. found the CCM was a useful guide for structuring the delivery of 
effective chronic disease management for patients receiving care at a free clinic.  
PCOS is a life-long condition with long-term complications. CCM offers a structure 
under which chronic conditions are managed successfully using a prevention- based approach as 
opposed to the traditional system that focuses on addressing acute care issues as they arise 
(Bodenheimer, Wagner, & Grumbach, 2002b). These studies identify that use of the CCM to 
develop a strategy for managing a chronic syndrome such as PCOS can be successful. This 
proposed project, dubbed “The PCOS Project”, will be based on the elements of CCM.  
Patients living with a chronic illness require different types of interaction and have 
different needs from a health care system than can be met in an acute care focused primary care 
system. The chronic care model was designed by the MacColl Institute for Healthcare Innovation 
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to reshape primary care systems to better meet the health care needs of those living with a 
chronic illness (Wagner, 1998).  
 
 The model is based on the successful interaction of an informed, activated, and 
empowered patient having productive interactions with a prepared proactive team. An informed 
activated patient is defined as a patient who seeks knowledge, is actively involved in self care, 
and is an active participant in the decision making about his or her own care with the health care 
providers. The model identifies six elements that are essential to bring about the productive 
interactions between the provider team and the activated patient in order to improve outcomes. 
These elements are also essential to creating the informed activated patient and the prepared 
proactive team.  The elements are: community involvement, health system leadership support, 
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self-management support, delivery system redesign, decision support, and clinical information 
systems (McCulloch, Price, Hindmarsh, & Wagner, 1998; Von Korff, Gruman, Schaefer, Curry, 
& Wagner, 1997; Wagner, et al., 1996a; Wagner, et al. 1966b).  When the six elements occur in 
the clinical setting, the result is improved patient outcomes for patients living with a chronic 
illness. 
Literature Review 
Chronic Care Model 
More than half of patients with a chronic illness have multiple health problems that 
require attention at each health care visit. As the number of patients with a chronic illness 
diagnosis increased, Wagner, et al.  (1996a) developed the CCM to correct the deficiencies of 
usual care systems to meet this group of patients‟ needs. The CCM is a set of concepts that focus 
on the infrastructure of ambulatory care systems to improve health care response to the needs of 
patients with a chronic illness. The concept of the model is to change from a reactive to a 
planned and proactive approach to managing chronic illnesses. CCM describes a reconfiguration 
of the ambulatory health cares system that shifts from acute episodic visits to planned, routinely 
scheduled visits that focus on function and prevention of exacerbations and complications 
(Wagner, 1998). 
The CCM model identifies elements of the health care system that lead to improved 
outcomes for individuals with a chronic illness. The six essential elements of the CCM are: the 
community, the health system, self-management support, delivery system design decision 
support, and clinical information systems. The community element encourages the use of 
community resources to meet the needs of patients and eliminates duplication of available 
services. The health system element focuses on creating a culture and organization of care that 
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promotes safe quality care. Self-management support places emphasis on the patient‟s role in 
managing his/her health through empowerment and education (Bodenheimer, 2005; Von Korff, 
Gruman, Schaefer, Curry & Wagner, 1997). Delivery system design assures the delivery of 
effective, efficient, clinical care and self-management support (Wagner, et al., 1996b). Decision 
support promotes clinical care that is consistent with evidence-based information and patient 
preferences (Wagner, et al., 1996b). Clinical information systems organize both patient and 
population information to facilitate efficient and effective care (Wagner, 1995). The combination 
of these elements improves satisfaction and health outcomes of patients with chronic illnesses. 
The Robert Wood Johnson Foundation authorized an independent evaluation of the CCM 
process for those health systems adopting the model. The evaluation team included members of 
the RAND Corporation (1999) and researchers from the University of California at Berkeley. 
This team evaluated 51 participating sites involving approximately 4000 patients with diabetes, 
congestive heart failure, asthma, and depression. The evaluation identified improvement in the 
element areas of the model. Patients with diabetes had a significant decrease in cardiovascular 
disease risks. Congestive heart failure patients were more knowledgeable, more frequently 
stayed on recommended therapy, and had 35% fewer hospital days. Patients with asthma and 
diabetes were more likely to receive appropriate therapy. Details of these findings are available 
through the RAND „Health Program Improving Chronic Illness Care Evaluation‟. As PCOS is a 
chronic health condition, improvement in patient health outcomes and satisfaction with the 
health care system would be expected after application of CCM.  
Missed or Delayed Diagnosis 
 A limited number of studies exist that address the effect of continuing health care 
education in preventing missed or delayed diagnoses. Most studies address specific diagnoses 
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and not the topic of continuing education and changes in diagnosis or disease management 
changes. The following studies were found to support continuing education and practice changes 
that improve diagnosis and care. 
Gandhi, et al (2006) conducted a retrospective review of 307 closed malpractice claims in 
which the alleged error was a missed or delayed diagnosis in the ambulatory setting. The purpose 
of the review was to develop a framework for investigating missed and delayed diagnoses, 
advance understanding of the cause, and identify opportunities for prevention.  
The most common errors (85%) occurred in a physician‟s office, and the primary care physician 
was the provider most commonly involved.  
The predominant reason found for a missed diagnosis was failure to order an appropriate 
diagnostic test followed by a failure to create a proper follow-up plan. Lack of knowledge of 
appropriate testing was the most common reason given for failure to order a diagnostic test. 
Other common errors causing a missed diagnosis in non cancerous diseases were delays by 
patients in seeking care, taking an inadequate history or physical exam, and failure to refer 
(Gandhi et al, 2006; Singh, Thomas, Myrna, & Peterson, 2007). 
The factors attributed to a missed or delayed diagnosis were failures in judgment, 
decrease in vigilance or memory, lack of knowledge, patient-related factors, and not performing 
a physical exam. Although the study examined multiple, significant causes of breakdown in 
either the system or the diagnostic process, human error was present as well. The human errors 
identified were reliance on the physician‟s knowledge or memory to ensure the correct test is 
ordered and poor communication strategies in the clinic setting. A patient-related factor of having 
complex disorders was also a reason associated with delayed or missed diagnosis (Gandhi et al, 
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2006). The conclusion of a study by Guradini, Talamini, Fiorillo, Lirutti, and Palese (2008) was 
knowledge is progressively lost if refresher courses are not held on a regular basis. 
Recommendations from Gandhi, et al. (2006) include changing the systems to alleviate 
the cognitive errors by reducing dependence on memory for appropriate testing and clinical 
diagnosis. Errors associated with follow-up and further evaluation can be decreased by forcing 
consideration of evidence-based diagnostic plans or second opinions. Gandhi et al (2006) also 
noted that for changes to have a maximum effect they must be easy to use and easily integrated 
into the workflow. For example incorporating clinical decision-making support, appropriate 
testing for diagnosis and appropriate follow-up in an electronic medical record will decrease 
missed or delayed diagnoses. 
Davis, Thomson, Oxman, and Haynes (1995) conducted a systematic review of studies 
on education strategies and interventions that assessed physician performance and health care 
outcomes. For this study, educational intervention was defined as any attempt to persuade 
physicians to modify their practice performance. Three quarters of the studies reviewed (n=75) 
were conducted in outpatient settings. They found that a physician reminder was an effective 
single-method intervention to yield an effective practice change. Other studies found that success 
in changing performance included reinforcing methods such as feedback or reminders. Barriers 
to change included: individual readiness to change, decreased motivation to change, a knowledge 
problem, or no perception of a gap between current knowledge and skills and knowledge needed 
to bring about the practice change. Knowledge deficit and memory loss over time are significant 
contributors causing missed or delayed diagnosis. Continuing education sessions or refresher 
sessions are one way to change the incidence of a missed or delayed diagnosis. Reminder 
systems such as electronic records that prompt reminders for providers are a way to positively 
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effect change in both diagnosis and management of patients. Based upon the findings of these 
studies an educational update and use of electronic prompt system should improve diagnosis and 
consistency in management of PCOS.  
Definitions of PCOS 
Several definitions of PCOS have been proposed in an effort to encompass women with a 
range of mild to more severe symptoms. In 1990, the National Institute of Child Health and 
Development (NCIHD) convened a consensus conference to define the diagnostic criteria for 
PCOS. Despite variability in opinions, the diagnostic criteria arising from the NIH conference, 
include women who have both chronic anovulation and evidence of androgen excess for which 
there is no other cause (Guzick, 2004).  
The European Society for Reproduction and Embryology and the American Society for 
Reproductive Medicine (Rotterdam consensus group) held an international consensus meeting in 
Rotterdam, Netherlands in 2003. The goal of this group was to create diagnostic criteria to define 
and diagnose PCOS. Although total agreement was not reached, the consensus of the Rotterdam 
group defined the diagnostic criteria as a woman who has at least two of the following three 
features present: (1) oligomenorrhea/amenorrhea, (2) clinical or biochemical signs of androgen 
excess, and (3) polycystic ovary by ultrasound scan, for which there are no other causes 
(Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group, 2004). Use of the 
Rotterdam criteria incorporates many women with PCOS who would have been missed by 
NCIHD criteria, thus increasing the prevalence to nearer 10%. 
In an attempt to resolve the differences between the two accepted definitions, the 
Androgen Excess Society (AES) task force performed a systematic review of medical literature 
to compose a judicious definition of PCOS (Azziz, et al., 2006).  They concluded that the 
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original 1990 NCIHD criteria should be accepted as the definition of PCOS with some 
modifications. Taking into consideration the opinion from the Rotterdam group, the AES task 
force identified nine different phenotypes that could be could be used as criteria in diagnosing 
PCOS based on the current knowledge. The nine phenotypes are: 1) hyperandrogenemia, 2) 
hirsutism, 3) oligoanovulation, 4) polycystic ovaries, 5) combination of chronic anovulation and 
androgen excess, 6) combination of oligomenorrhea/amenorrhea, clinical or biochemical signs of 
androgen excess and polycystic ovary by ultrasound scan, 7) oligomenorrhea/amenorrhea, 8) 
impaired glucose tolerance/insulin resistance, and 9) metabolic syndrome (Azziz, et al.) 
 AES defines PCOS as a disorder of androgen excess with an ovarian etiology and/or 
consequences after exclusion of other known androgen disorders (Azziz, et al.). The absence of 
clinical or biochemical indicators of excess androgen in women under the age of 40 with other 
PCOS phenotypes makes the diagnosis of PCOS less certain (Azziz, et al.). Thus, three accepted 
definitions of PCOS exist in health care (Azziz, et al., 2006; Guzick, 2004; The Rotterdam 
ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004). 
Etiology and Pathophysiology of PCOS   
PCOS is the most common endocrine disorder of women, yet the etiology and 
pathophysiology remain unknown. Defects in the reproductive endocrine pathways create a cycle 
of abnormal hormonal secretions that cause the range of observed phenotypes. Many theories 
have been proposed. They include 1) a complex genetic defect, 2) a defect in insulin action and 
secretion causing insulin resistance and hyperinsulinemia, 3) a defect of androgen synthesis that 
leads to enhanced ovarian androgen production, or 4) a neuroendocrine defect causing an 
exaggerated lutenizing hormone (LH) pulse and frequency, causing excess adrenal androgen 
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production (Tsilchorozidou, Overton & Conway, 2004). Each of the theories is based on what the 
theorist identifies as the primary defect causing the self-perpetuating cycle of abnormalities. 
The etiology is not clearly understood but studies suggest a genetic (autosomal-dominant) 
component. PCOS is found predominantly in families. Studies attempting to define the specific 
genetic cause suggest that PCOS is a complex multigenic disorder. The clinical and biochemical 
presentation is influenced by environmental factors as well (Abbott, Dumesic & Franks, 2002; 
Diamanti-Kandarakis & Piperi, 2005). Based on animal studies, Abbott, et al. suggests that 
PCOS is a linear process that begins in utero. They postulate that either or both hyperandrogenic 
fetal ovaries or the hyperandrogenic adrenal cortex are the cause of excess fetal androgen 
production beginning in the second trimester.  Androgens are potent gene transcription factors 
and induce other critical transcription factors effecting gene expression. This implies fetal 
androgen excess in female fetuses may reprogram coding in multiple organ systems that will 
later appear as the varying phenotypes of PCOS (Abbott, et al.). Though not proven, there is 
evidence to support the idea that a genetic defect causes the fetal ovary theca cells to over 
produce androgens causing the cascade of changes in utero that lead to the syndrome (Urbanek, 
et al., 2006). 
 The cause of insulin resistance (IR) and hyperinsulinemia remain uncertain. 
Abnormalities in post-insulin signaling and abnormal insulin secretion have been identified in 
women with PCOS. The insulin-signaling defect in adipocytes and skeletal muscle is specific to 
PCOS. IR in PCOS occurs by a different mechanism than in women who are obese or have type 
2 diabetes mellitus without PCOS (Corbould, Zhao, Mirzoeva, Aird & Dunaif, 2006). Androgens 
are believed to contribute to peripheral insulin resistance in PCOS by acting directly on the 
insulin-signaling pathways (Diamanti-Kandarakis, 2008). 
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Sixty to 80% of women with PCOS have hyperandrogenemia (Diamanti-Kandarakis, 
Papiliou & Palimeri, 2006). The over production of androgens by theca cells is a response to 
increased stimulation of the ovary by LH. Theca cells in women with PCOS more efficiently 
convert androgenic precursors to testosterone than do normal theca cells (Ehrmann, 2005). 
Follicle-stimulating hormone (FSH) is responsible for regulating aromatase activity of the 
granulosa cells. The level of FSH determines the amount of estrogen that is made from androgen 
precursors (Ehrmann). FSH levels are often decreased in PCOS (Ehrmann; Marrinan, & Stein, 
2007).   
Insulin is both a direct and indirect contributor to hyperandrogenemia. It acts 
synergistically with LH to enhance theca cell androgen production. Hepatic synthesis of sex 
hormone-binding globulin (SHBG) is inhibited by insulin. Elevated levels of insulin decrease 
SHBG so it is not available to bind with testosterone, thus increasing circulating levels of free 
testosterone (Ehrmann, 2005). The increased androgens also inhibit the production of SHBG 
(Marrinan, 2007). Elevations of free testosterone cause worsening clinical signs of 
hyperandrogenism. Higher androgen levels contribute to central/android obesity, which increases 
insulin resistance and worsening PCOS symptoms (Azziz, et al., 2005; Ehrmann). 
Normal menstrual cycles occur when the hormone levels and feedback pathways of the 
hypothalamic-pituitary-ovarian axis function appropriately. In PCOS, the hypothalamic-
pituitary-ovarian axis is disturbed. The defect that causes this disturbance is unknown. There is 
thought to be an abnormality of the gonadotrophin-releasing hormone pulse generator of the 
hypothalamus. It is unclear if this defect is primary or secondary (Marx & Mehta, 2003). 
Elevated LH levels and normal or decreased FSH are found in PCOS. Also, increased levels of 
free estrogen, primarily in the form of estrone and estradiol are found. Elevated estrogens cause a 
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feedback effect on the pituitary that leads to further suppression of FSH and increased frequency 
and amplitude of pulsating release of LH. This hormonal environment increases the production 
and release of androgen precursors by theca cells. These androgen precursors are converted 
peripherally to primarily estrone, which in turn enhances the feedback to the pituitary 
perpetuating the cycle of elevated LH, decreased FSH, and increased androgen production 
culminating in abnormal menstrual cycles and hyperandrogenemia (Ehrmann, 2005; Marrinan & 
Stein, 2007).  
Clinical Consequences of PCOS Pathophysiology 
Early detection of health status changes is an important part of the prevention plan. 
Prevention or delay of progression of PCOS involves ongoing secondary prevention aimed at 
early disease detection, thereby increasing opportunities for interventions to prevent progression 
of the disease and emergence of symptoms. Prompting providers to order recommended 
surveillance screenings is built into HealtheWV charting program. Electronic patient record 
systems that alert providers when recommended screening tests are due are important for 
increasing consistency in managing a chronic illness and improving patient outcome. Potential 
sequelae resulting from pathophysiology are included in both the educational offering and in the 
electronic chart generated plan. The consequences of PCOS are the foundation for the 
development of the program template.  Each potential health threat from PCOS is described in 
the following sections of the paper, as it will be incorporated into the educational program and 
into the electronic charting program template.   
Endocrine and Gynecological 
Thirty to 40% of women with PCOS have impaired glucose tolerance. Type 2 diabetes 
mellitus will develop in 10 to 45% of women with PCOS by the time that they reach their forties. 
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Obesity is present in over 50% of women with PCOS. Insulin resistance and hyperinsulinemia 
are common findings in both obese and non-obese women with PCOS. Independently, obesity 
also leads to insulin resistance. Therefore, obese women with PCOS have two contributing 
factors causing them a greater degree of insulin resistance than non-obese women with PCOS 
(Tsilchorozidou, et al., 2004). Endocrine disturbances in PCOS lead to increased blood pressure, 
increased low-density lipoprotein (LDL) cholesterol, and decreased high-density lipoprotein 
(HDL) cholesterol. These are known significant risk factors for developing cardiovascular 
disease and metabolic syndrome (Ehrmann, 2005; Sheehan, 2004). Elevated androgens cause 
hirsutism in 60%, acne in 15% to 25%, and androgenic alopecia in an estimated 5% of women 
with PCOS. Hirsutism is a most reliable index for elevated androgens. AES states PCOS cannot 
be diagnosed without either clinical or biochemical evidence of hyperandrogenism (Azziz, et al., 
2006).    
Psychosocial Sequelae  
In Snyder‟s (2006) study, women with PCOS recognized themselves as different from 
other women without the disease. Higher than average weight gain, lack of regular menstrual 
cycles, heavy or continuous bleeding with occasional menses, growth of excessive unwanted 
facial and body hair, and severe mood swings were identified as the characteristics that made 
PCOS sufferers feel different. They also expressed that feeling different from other women 
created a sense of insecurity and isolation (Snyder). The study participants stated that hirsutism 
and infertility problems made them feel less feminine as though womanhood had been stolen 
(Kitzinger & Wilmot, 2002; Snyder).  
Obesity also contributed to a sense of being not normal or not looking like the media 
portrayal of femininity (Snyder, 2006). Women with PCOS define a normal female as one who 
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looks more female (without hirsutism), possesses a beautiful complexion, and has regular 
menstrual cycles (Snyder). A 1998 study by Cronin, et al. of 100 women with PCOS found while 
some women were concerned about irregular menses and infertility, weight or hirsutism caused a 
greater negative impact on their quality of life. 
There is an association between obesity in young girls and PCOS. Childhood obesity may 
be the initial symptom of PCOS (ACOG, 2006). Trent, Rich, and Austin (2002) using a health 
related quality of life (HRQoL) inventory determined that adolescent girls with PCOS self- 
reported a statistically significant reduction in general health perceptions, behavior, physical 
function, and family activities compared to adolescent girls without PCOS.  
Cancer Risks 
Endometrial hyperplasia, as well as endometrial, ovarian and breast cancer are associated 
with PCOS. The endometrial hyperplasia and cancer are attributed to the continuously estrogen 
stimulated endometrium that goes unopposed by progesterone due to anovulation. Endometrial 
cancer is also associated with obesity and type 2 diabetes mellitus, which is prevalent in women 
with PCOS (Hardiman, Pillay, & Atiomo, 2003).  Determining the cause of the increased 
prevalence of breast and ovarian cancer is difficult. Obesity, anovulation, and infertility are 
independent risk factors associated with breast and ovarian cancer, and they are common 
problems in PCOS (Balen, 2001).  
Sleep Apnea 
An increased prevalence of obstructive sleep apnea that cannot be explained by obesity 
alone has been found in women with PCOS. A study by Fogel, Malhotra, Pillar, Pittman, Dunaif, 
and White (2001) found that, after controlling for body-mass index (BMI), the risk of sleep-
disordered breathing was increased by a factor of 30. Fogel, et al. determined that insulin 
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resistance seems to be a stronger predictor of sleep-disordered breathing than age, BMI, or 
elevated free testosterone. 
Infertility, High Risk Pregnancy, and Potential Delayed Lactogenesis 
A common reason why women with PCOS seek care is infertility. Anovulation is a 
hallmark of the disorder. Anovulation is due to the increased number and the disturbed 
maturation of recruited ovarian follicles resulting from androgen excess, increased LH, and 
decreased FSH stimulation of the ovary (Diamanti-Kandarakis, 2008; Diamanti-Kandarakis, et 
al., 2006). Women with PCOS who desire pregnancy are usually referred to a gynecologist or 
reproductive endocrinologist for infertility treatment. Obesity is a factor that contributes to 
infertility. Increasing body mass index (especially >35) yields a decrease in fecundity (Legro, 
2007). 
 There is conflicting evidence about the increased risk of early spontaneous pregnancy 
loss in women with PCOS. The role of obesity as a cause of early pregnancy loss is a 
confounding, independent risk factor. Early pregnancy loss is associated with hyperinsulinemia, 
which is present in both obese and non-obese women with PCOS. It is thought that reduced 
insulin sensitivity may cause an endometrial inflammation reaction, which prevents implantation 
and leads to early pregnancy loss (Siassakos, & Wardle, 2007). 
 Antenatal complications associated with PCOS include: impaired glucose tolerance, 
gestational diabetes mellitus, pregnancy-induced hypertension, and pre-eclampsia. Iatrogenic 
premature births and increased rates of cesarean births are also associated with PCOS (Marx, & 
Mehta, 2003; Siassakos, & Wardle, 2007).  A postnatal complication for large babies of obese 
women is the tendency to become obese adults. There is concern that in utero fetal programming 
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of growth hormone and insulin growth factors may influence postnatal growth and insulin 
sensitivity of individuals (Siassakos, & Wardle).  
Endocrine issues such as polycystic ovary syndrome can affect milk production. Case 
studies by lactation consultants report some women with PCOS who have successfully become 
pregnant and successfully initiated breast feeding. However, such women are often unable to 
produce a sufficient volume of milk to nourish a growing infant (Amir, 2006; Betzold, Hoover, 
& Snyder, 2004). Although some women with PCOS have no problem breastfeeding, there 
appears to be a group of women with PCOS who have underdeveloped mammary tissue that 
cannot produce an adequate milk supply (Marasco, Marmet, & Shell, 2000). Amir noted that the 
inability to successfully lactate may be related to hormonal imbalances or increased serum 
androgen levels. Elevated androgen levels are associated with decreased breast cell proliferation 
and lack of sufficient breast tissue development to maintain milk production. The causes of 
delayed or failed lactogenesis II result from one of many endocrine errors or insufficient 
mammary tissue (Betzold, et al.; Marasco, et al.).  
Opportunities for the Project 
The clinical setting in which the project was implemented provided opportunities that 
support the initiation of such a project. The clinic offers services to adults who have no insurance 
and meet certain income guidelines. The income guidelines are based on family size and living 
on a gross salary at or below 150% of the poverty level. This clinic depends on a variety of 
physicians and midlevel providers, who receive either minimal reimbursement or who volunteer 
their time free of charge, to provide care for this population of patients.  Over time, patients do 
not see the same provider or group of providers on a consistent basis, so continuity of care is not 
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always possible. Despite the limitations of the free clinic, the goal of this clinic is to deliver 
quality care for its clients. 
The clinic acquired an electronic medical record system from HealtheWV, which includes 
electronic note charting and chronic disease templates that remind health care providers to order 
required tests to monitor the health status and patient response to therapy. For the proposed 
project, the project manager (this author) proposed development of an evidence-based electronic 
PCOS patient management and charting template, which could be incorporated into the 
electronic system. The goal is for the HealtheWV electronic system to assist providers to provide 
consistent, evidence based, high quality care for women with PCOS. It was proposed that when a 
diagnosis of PCOS is made, an evidence-based management plan would be generated by the 
HealtheWV electronic system, following the same computer generated format used for other 
chronic diseases. This computer capability should improve the consistency of management plans 
for therapies and required health care surveillances, which are expected to improved outcomes 
over a life time for women with PCOS. 
Congruence with Organization‟s Strategic Plan 
 This project encompasses a holistic health care approach to the diagnosis and 
management of a serious chronic disorder that affects the health of a significant portion of 
women in WV and in the United States as a whole.  The PCOS project is compatible with the 
mission of the free clinic to improve the health and well being of non-insured, lower income 
women in WV through education and health care. The PCOS project focuses on prevention of 
negative health sequelae secondary to a chronic health problem for women who lack the 
financial resources to obtain this level of health care in the traditional health care system. Women 
from Appalachian cultures tend to place the needs of their families before their own health; 
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therefore, they are less engaged in preventive health care (Patton, 2005). First line therapy for 
PCOS includes life style changes and preventive care that require support from health care 
systems (Kovacs, 2006).  
Project Description 
An in-depth review of the literature relevant to PCOS was completed and the evidence- 
based recommendations were organized into a diagnostic guide and management plan prior to 
implementing the two part project. The first aspect of the project focused on improving the 
diagnosis of PCOS at a free primary care clinic. An educational session was conducted during 
the quarterly provider staff meeting at the clinic.   Accepted definitions used to identify the 
diagnostic characteristics and symptoms that are present in women with PCOS were emphasized. 
A list of both primary and secondary PCOS symptoms that should prompt the provider to 
consider PCOS as a differential diagnosis for women with such symptoms was described.  A 
brief review of pathophysiology was included to enhance provider understanding of the 
complexity of the biochemical interactions and feedback pathways of this endocrine disorder. 
Understanding the complex pathophysiology should enhance the provider‟s ability to diagnosis 
PCOS early as well as increase his or her understanding of the importance of early intervention.  
An evidence-based patient management guide was created and incorporated into the 
HealtheWV electronic patient management system for providers to help them manage or prevent 
the wide variety of sequelae that can result from PCOS. HealtheWV is an electronic patient 
record system that enables chronic illness management plans to be pre-programmed into the 
system. When a patient is diagnosed with a chronic illness, the system will prompt the provider 
to order selected screening tests specific for the diagnosis. This system also prompts the provider 
as to which and when routine health maintenance surveillance tests are due.    
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Project objectives 
The objectives are: 
1. To provide an educational session at a free clinic to increase providers‟ knowledge   
about diagnosing PCOS;  
2. To assess health care providers' knowledge about PCOS and its management before   
and after an educational session; 
 3. To develop a management plan and imbed the plan in an electronic patient record 
system at the free clinic to improve efficiency and quality of care for PCOS 
management;  
4. To evaluate the effectiveness of an electronic management plan in increasing the 
frequency of diagnosis, and appropriateness of treatment of PCOS at the free clinic. 
Project Design  
Timeline 
The project was initiated in August 2008 and continued through 2009. For a step-by-step 
timeline please see Appendix A. 
Resources 
There is minimal expense to the free clinic. HealtheWV system has templates for other 
common chronic illnesses currently in place. The electronic charting system is a recent 
acquisition of the clinic. By designing the PCOS template at this time, no technician salary cost 
will be incurred to assist the project manager in loading the data and creating the pathways that 
signal the care provider as to which tests to order if indicated for the diagnosis, and when 
recommended health screenings are due.  
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Cost savings for patients and the health care clinic will require a cost analysis to 
determine savings created by decreased expenditures arising from sequelae and/or 
hospitalizations for problems that can be avoided through timely diagnosis and appropriate 
management of PCOS. However, the cost analysis should not be performed until the project has 
been implemented for an extended period of time that will be determined.  Cost analysis will not 
be a part of this project. Patient care satisfaction for women with this disease is anticipated to 
improve, as they perceive a health care system that is responsive to the specific issues associated 
with PCOS.  
Budget 
 The budget to implement the PCOS project is included in Appendix B. 
Evaluation  
 PCOS is a women‟s health issue that is currently under diagnosed. When PCOS is 
diagnosed, consistency in initiating management and recommending surveillance plans for 
secondary prevention of the complications of PCOS often does not occur. A consistent evidence-
based plan is essential to delay or prevent the multiple health problems that can occur in women 
with PCOS. It is essential for the health of this group of women that efforts are made to improve 
the diagnosis and management of this chronic endocrine disorder.  
In association with an educational session, both a pre- and posttest knowledge assessment 
about diagnostic criteria and laboratory testing were completed with providers at the free clinic 
(Appendix C).  Such testing indicated whether learning had taken place and can serve as 
indicator about the effectiveness of the education strategy.  The clinic at which the project was 
conducted has quarterly provider meetings. The agenda for the provider meetings includes a time 
slot for continuing education. The PCOS educational session was presented at the May meeting. 
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A PowerPoint presentation along with a question and answer opportunity was offered (Appendix 
D).  
 To assess their prior knowledge about PCOS, a tool developed by this author was 
completed by the providers. After providing an educational session that included a question and 
answer session, the same tool was used to determine if providers‟ knowledge had improved. 
Knowledge acquisition was assessed by using a matched sample t-test to compare the difference 
in means between the two sets of test scores.  
 A PCOS management template was developed by the Project Director (Appendix E) and 
incorporated into the clinic‟s electronic patient data system to be utilized by providers. A chart 
review was conducted before the template was made available and again 3 months after the 
PCOS management template was loaded into the HealtheWV electronic patient management 
system.  The chart review was intended to determine whether providers evaluate patients who 
present with abnormal menstrual cycles and/or clinical or biochemical symptoms of excess 
androgen for PCOS using the appropriate laboratory testing. The chart review noted whether an 
evidence-based plan was initiated at the time of diagnosis prior to the initiation of the electronic 
plan.  Successful use of the electronic PCOS management plan for this project was defined by 
30% or more of the patients diagnosed with PCOS having a management plan initiated in the 
HealtheWV system.  
 Three months after the education session, 50 charts of women presenting with abnormal 
menstrual cycles and/or clinical or biochemical symptoms of excess androgen were evaluated 
using the same criteria as the pre-intervention chart review. The post intervention chart review 
also added the question: Is the electronic PCOS management initiated.   
 
                                                                                                                          PCOS Project 27 
Results 
Objective 1. 
The first objective was to provide an educational session. This objective was met on May 
14, 2009. An educational information session (Appendix D) about diagnosis and long-term 
management of the health care of women with PCOS was presented at the provider staff 
meeting.  
Objective 2. 
Assessment of health care providers‟ knowledge about diagnosing and managing PCOS 
was the second objective. To measure the initial knowledge level and a change in knowledge 
after education, a pre-test and post test (Appendix C) were completed by each participant. The 
test consisted of five questions developed by the author. The questions were designed to evaluate 
the five learning objectives for the education session. The test questions were evaluated for 
clarity and correct content by an expert in women‟s health. The objectives for the educational 
session were:  
1) The participant will be able to state the diagnostic criteria for PCOS, 
2) The participant will be able to identify other causes of excess androgen that must be  
    excluded,  
3) The participant will be able to identify initial laboratory tests for diagnosis and  
4) The participant will be able to name the risks associated with PCOS.  
 Because of the varying schedules and infrequency of providing services to patients at the 
clinic by some of the providers, the participants were asked to complete the pre and post test 
before and immediately after the session. Participants were asked not to provide any identifying 
information on the tests. Ten participants completed the pretest and demonstrated a mean 
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knowledge score of 1.5 on a scale with a range of 0 to 5(O = lower and 5 = higher). Eight 
participants completed the post test with a mean score of 4.25. Two providers at the session 
chose not to participate. Due to the small sample size, a Mann-Whitney test was used to 
determine whether there was a change in knowledge before and after the educational session. A 
significant change in knowledge (p = .000) occurred as a result of the educational session. (See 
tables 1, Appendix E and table 2, Appendix F) 
To assess specific areas of knowledge deficit the number of correct answers to each 
specific question on the pretest was calculated. The range of questions answered correctly was 
zero to three out of five total questions. Acknowledge deficit about PCOS existed for this group 
of providers. No provider was able to identify the three diagnostic criteria for PCOS. After the 
session, seven of eight (87.5%) of providers correctly identified the three diagnostic criteria. At 
the pretest, one provider, out of 10 (10%) identified other causes of hyperandrogenemia that 
must be excluded; and six of eight (75%) at the post test could correctly identify other causes. 
Two providers out of 10 (20%) identified the recommended diagnostic laboratory tests prior to 
the educational session, and six out of eight (75%) correctly identified the correct laboratory tests 
after the educational session. Five providers of 10 (50%) could identify the potential risks 
associated with PCOS prior to the educational session and eight of eight (100%) identified the 
risk factors correctly after the educational session. The first line therapy of choice was correctly 
identified by seven out of 10 providers (70%) prior to the session, and seven out of eight (87.5%) 
after the educational session. Improvement in knowledge levels in the five areas identified by the 
learning objectives resulted from the educational session. (See figure 1, Appendix G) 
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Objective 3. 
 Due to limitations in current technology, an electronic provider prompt to consider 
PCOS as a differential diagnosis when symptoms are entered into the e-chart was not able to be 
embedded into the system. Due to software restrictions, a modified template (Appendix H), with 
a recommended health management plan for this chronic disease was created as part of the 
clinic‟s electronic charting system.  
Objective 4.    
To evaluate the effectiveness of an electronic management plan in increasing the 
frequency of diagnosis, and appropriateness of treatment of PCOS at the free clinic a pre and 
post chart review was completed.  Five hundred and thirty- five charts of women cared for by the 
eight providers who agreed to participate in the study were reviewed for inclusion criteria. The 
inclusion criteria were patient charts with documented amenorrhea, abnormal menstrual cycles or 
abnormal or dysfunctional uterine bleeding, and with clinical symptoms of excess androgens. 
These clinical symptoms included hirsutism, acne, or alopecia.  Thirty-four charts were found to 
meet the inclusion criteria. Since PCOS affects 5-10% of women of reproductive age, 34 out of 
the 535 charts meeting the criteria for inclusion represented an appropriate sample.  
For data collection, two questions were posed. The first question posed was „Are the 
appropriate diagnostic laboratory tests ordered?‟ The response was either yes or no.  The criteria for 
a yes response for charts prior to the educational session included women who had a diagnosis of 
PCOS prior to admission to the clinic system, and those who had been diagnosed with PCOS using 
the conventional diagnostic testing that was the standard of care at the time of diagnosis. 
Conventional diagnostic testing include: lutenizing hormone levels, follicle stimulating hormone 
levels, thyroid stimulating hormone levels, total testosterone levels, fasting glucose levels, and an 
                                                                                                                          PCOS Project 30 
insulin level. Evidence-based studies currently recommend a prolactin level, thyroid stimulating 
hormone level, total testosterone levels, and 17 hydroxyprogesterone level for initial diagnostic 
testing, and further studies can be added if indicated by the results of the initial findings. Of the 34 
total charts, 31 charts met the criteria for inclusion prior to the educational session and three new 
charts entered the system after the educational session. 
Three months after the educational session a chart review, using the same two questions 
was conducted to determine whether appropriate diagnostic laboratory testing was ordered when 
undiagnosed women presented with symptoms suggesting PCOS, as well as to determine if 
appropriate screenings were ordered for women already diagnosed with PCOS. Post education, 23 
charts were available for review. Eleven of the 31 pre-educational charts were lost to follow up 
and three new charts entered the system. The 23 eligible charts were then further reviewed for 
documentation by the providers specifically noting if the appropriate diagnostic laboratory 
assessments, if indicated, had been ordered, and if the appropriate metabolic screening tests were 
obtained if they had not been performed within the year. The same questions were used to select 
charts for the post-educational review as had been posed in the pre- education chart review.   
1) Were the appropriate diagnostic laboratory assessments performed when women presented 
with abnormal menstrual cycles and a clinical sign of excess androgen? (yes or no) 2) Were 
appropriate metabolic screen testing obtained if PCOS was diagnosed? (yes or no)  
Post educational session, the question about appropriate metabolic screen testing was answered 
yes if four studies, prolactin level, thyroid stimulating hormone level, total testosterone level, and 
17 hydroxyprogesterone level were ordered, or the diagnosis of PCOS was made prior to the 
educational session (n = 23). If the diagnosis PCOS had been made prior to the educational 
session, one would not expect a second set of diagnostic laboratory tests to be ordered to 
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diagnose PCOS again so those charts received a yes for appropriate diagnostic laboratory testing. 
Prior to the provider‟s educational session appropriate testing for diagnosis was found in 10 of 
31 cases (32.3% of the time). Post educational session appropriate diagnostic testing was found 
in 16 of 23 cases (69.6% of the time). (See table 3, Appendix I and figure 2, Appendix J)  
Flow Chart for Patient Chart Selection 
  
For the 20 cases present before and after the education session, a Pearson Chi-square was 
use to determine if there was a significant difference in providers ordering appropriate diagnostic 
tests three months after the educational session. A Chi-square test for independence indicated no 
significant difference in pre and post educational session for ordering appropriate diagnostic 
tests, X2 (1, N = 20) = .73, p = .143. 
Prior to the educational session appropriate metabolic screening tests used as part of a 
chronic management plan were ordered in 20 of 31 cases (64.5%) and post educational session 
such tests were ordered 19 of 23 (82.6% ) times. (See table 4, Appendix K and Figure 3, 
Appendix L).  
For the 20 cases evaluated before and after the education session, a Pearson Chi-square 
was use to determine if there was a significant difference in providers ordering appropriate 
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metabolic screening tests three months after the educational session. A Chi-square test for 
independence indicated no significant difference in pre and post educational session for ordering 
appropriate metabolic screening tests, X2 (1, N = 20) = .000, p = 1.000. 
Of the three new cases that presented with symptoms of PCOS, two had the appropriate 
diagnostic and metabolic screenings ordered by the provider. The third woman was referred to 
the women‟s health clinic within two weeks of her new patient visit for evaluation at the clinic. 
Discussion 
Discussion of the project 
  The Chronic Care Model served as the guide for this project. The model blends 
the community resources and policies with the organization of the health care system to improve 
patient outcomes.  This project focused on the health care system‟s concept, and specifically the 
clinical information system‟s element. It is essential for the practice team to be prepared and 
proactive in the management of a chronic illness. In a busy clinic, utilization of technology and 
clinical information systems is especially efficacious when a team of providers cares for 
chronically ill patients. The use of electronic templates, which can provide care reminders, aids 
the healthcare team in providing timely and consistent care for a patient without relying on the 
memory of both the patient and the provider to follow a plan. The clinic, in which this project 
was staged, operates by using a team of primary care providers. The use of the electronic 
charting system has the potential to keep the team prepared and proactive in the care of women 
with PCOS.  However the limited technology of the computer charting system and the inability 
to have the appropriate prompts for PCOS embedded does not assist the provider to remain 
proactive. This project does not support CCM being effective at this time. 
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Discussion of the findings 
Objective1.  
Twelve providers attended the quarterly provider meeting, which occurred as scheduled.  
Of the twelve providers present eight consistently provide primary care for women who attend 
the clinic. A discussion including questions and answers by participants occurred during and after 
the power point presentation. The eight providers who regularly manage the health care of 
women are included in the evaluation data. Three of the excluded members are sub-specialist and 
do not provide primary health care. The fourth excluded practitioner is new to the clinic and had 
not begun caring for patients until after initiation of the project.  
Objective 2. 
The decision to require the group to complete the post test immediately after the session 
was due to the dynamics of the group. The providers practice on a limited, part- time basis, from 
four hours per month to 8 hours per week, and on different days. It was determined that few 
providers would complete the post education questionnaire if the testing was not requested 
immediately after the education session because of the sporadic and part- time schedules of this 
groups of providers. Loss of data post-educational session with this small number of providers 
would affect the findings. Specifically for this reason, providers‟ knowledge was not tested again 
several months after the educational session. Testing of knowledge about PCOS at three or six 
months after the educational session would possibly show a no significant change from prior to 
the initial educations session due to the natural loss of knowledge over time (Davis, et al.1995).  
Since PCOS is a common women‟s health problem, one can assume that this group of 
providers had obtained baseline knowledge about PCOS during their professional education.  
Yet, the provider‟s  mean test score on the pretest was low and showed a significant 
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improvement after the educational session indicating that their knowledge about evidence- based 
care for diagnosing and managing PCOS was deficient.  Studies by Davis, et al. (1995) and 
Guradini, et al.(2008) support the need for refresher courses for providers to alleviate errors, 
which occur due to decrease in vigilance or memory, and/or lack of knowledge by providers. The 
educational session significantly improved the health care providers' knowledge about PCOS and 
its management. Refresher courses or continuing education sessions are required to prevent 
natural loss that occurs over time (Davis, et al.; Guradini, et al.) and should be offered at regular 
intervals. 
Although testing was not performed to assess whether long term the knowledge about 
PCOS was retained, it is a positive finding that three new patients, with symptoms, who entered 
the system after the educational session, were either appropriately managed or were referred by 
the primary care provider to a woman‟s health provider to be evaluated for PCOS. 
Diagnostic criteria and laboratory testing that is required to make a diagnosis of PCOS 
were the two areas of greatest knowledge deficit. A predominant reason missed diagnoses occur 
and there is a failure to create a long-term management plan is failure on the part of the provider 
to order appropriate diagnostic tests (Gandhi et al., 2006; Singh et al., 2007). Provider 
knowledge deficit and forgetfulness over time were identified by Gandhi et al. (2006) as major 
contributors to failure to order appropriate diagnostic testing. These studies support the finding 
that the greatest area of knowledge deficit for this group of providers is identification of 
diagnostic criteria and laboratory testing. Provider reminders were identified as an effective 
single-method producing effective practice change (Davis, et al., 1995). This new electronic 
system did not possess the technology necessary to provide a “pop-up” electronic prompt that 
would suggest differential diagnoses and diagnostic protocols when symptoms are entered into 
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the e-chart. Because the Healthe WV system could not provide diagnostic criteria, a guide to 
laboratory blood tests for diagnosis with the diagnostic values, and the recommended laboratory-
screening schedule was given to each provider participant as a laminated, pocket size card 
containing the information. Prior to the educational session, providers did know that the first line 
management for PCOS is lifestyle changes. Documentation of lifestyle changes is part of the 
selection menu in the plan section of the electronic chart that is used for each visit. 
Objective 3. 
An objective was to develop a management plan and imbed the plan in an electronic 
patient record system at the free clinic. Prior to starting the project, a discussion was held with 
the software developers of the electronic charting system about the possibility of developing a 
template for incorporating clinical decision making support, appropriate testing for diagnosis and 
appropriate follow-up. Both the software company and the clinic granted temporary 
administrative status to this author so the template for chronic management could be designed 
based on the current capability of this system (Appendix E). 
Computer technicians designed the basic electronic patient record template with basic 
knowledge about the standard structure universally used to create a patient visit note.  These 
developers were not health care or content experts. While this system is designed to allow for the 
development of templates that indicate the management for chronic illnesses, it does not have the 
capability to organize patient data into clinical algorithms, or suggest differential diagnoses for a 
set of signs and symptoms.  Nor does this system allow for variations required to individualize a 
patient care plan from a standard care plan. Perhaps this is due to the limitations with current 
technology or the failure of software developers to understand and respond to this type of 
provider need in a busy clinic. The CCM has delivery system design, decision support, and 
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clinical information systems as three of the six elements that are necessary in a health system to 
create a prepared proactive practice team, which lead to improved patient outcomes (McCulloch, 
et al., 1998; Von Korff, et al., 1997; Wagner, et al., 1996a; Wagner, et al. 1966b).  Use of an 
electronic system that is sophisticated enough to suggest differential diagnoses based on 
symptoms could decrease missed or delayed diagnoses that occur from failures in judgment, 
cognitive errors due to dependence on memory, or lack of provider knowledge (Gandhi et al., 
2006).  
In designing the note template, selection of characteristics for the patient review of 
systems section and physical findings for the examination section were limited. Each e-chart 
section provides a choice of “other” and a pencil icon so the provider can type in any finding that 
is not on a drop down menu. There was not an option of adding the Ferriman and Gallwey 
hirsutism scale (Wild, Vesely, Beebe, Whitsett & Owen, 2005). However, hirsutism, which was 
not on the general template prior to the project, was added as a selection on the drop down menu 
in the endocrine section of the review of systems. In the skin section of the physical exam area, 
the provider is able to select a face and body image on which areas can be identified with a typed 
in description of the finding from the physical examination.  
The basic templates provided in HealtheWV do include appropriate screening intervals 
based on the U.S. Preventive Services Task Force (USPSTF) (2009) or other expert panel‟s 
recommendations for the population at large, and prompts for providers, which indicate that a 
surveillance screen or monitoring test is due. When development of the PCOS template began, it 
became evident that screening interval prompts in the e-chart could not be changed from the 
interval set by USPSTF for the general population to an appropriate interval for patients at high 
risk for developing a disease, or for chronic management if the specific disease existed. For 
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example, screening intervals for lipid panels in the system are those recommended by USPSTF 
(2009) for a person who is not at risk and with normal values at their most recent screening. 
While frequency guidelines for lipid screening for women with PCOS are not specified, these 
women are at a greater risk for developing dyslipidemia. The software does not permit changes 
in the template to prompt providers to screen at closer intervals that should be considered for 
women with PCOS. While this does not prohibit the provider from ordering a surveillance test at 
a closer interval, a more frequent prompt option for the provider is not available. Without the 
closer interval prompts, screening is now dependent on the memory of the provider. The study by 
Gandhi et al. (2006) recommends changing systems to alleviate cognitive errors by reducing 
dependence on memory for appropriate testing and clinical diagnosis. Errors associated with 
follow-up and further evaluation can be decreased by forcing consideration of evidence-based 
diagnostic plans (Gandhi et al.).  Perhaps as technology develops further the template can be 
adjusted to initiate closer interval prompts for patients at higher risk. A systematic review by 
Davis, Thomson, Oxman, and Haynes (1995) found that a simple reminder system is an effective 
single-method intervention to improve provider performance for clinical care.  
The CCM upon which this project was designed, states that improved outcomes for 
people with chronic illnesses depend on productive interaction between informed patient and 
prepared proactive provider team.  Having a template that prompts providers about the ongoing 
plan of care helps them to remain proactive. By sharing the plan of care with the patient, the 
patient becomes informed and can become self-directing in managing his or her health plan. 
Objective 4 
Although a management template for PCOS exists in Healthe WV system, the clinic 
system‟s current method of template selection for a patient visit does not allow the provider to 
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select a specific template for charting. As patients arrive for a health care visit, they are 
registered and then initially evaluated by a medical assistant. Thus the medical assistant is the 
person who selects the note template when commencing the visit note, not the provider. The 
medical assistant may not be aware of the diagnosis or purpose of the visit unless the patient tells 
them. Often the purpose of the visit or a diagnosis may change after further patient evaluation by 
a provider. It is not a simple task to change the template during the visit after the management 
template is initiated by the medical assistant. The patient‟s vital signs and any notes made by the 
nursing staff do not automatically appear in a new template window if a different template is 
selected later. Thus, the PCOS template often was not selected.  
This project proposed to evaluate selection and use of the PCOS template three months 
after the educational session.  The option for the provider to select the template was not feasible 
in the clinic setting. The purpose of the template was to create an electronic reminder system for 
providers with the goal of improving the appropriate diagnosis and management of women with 
PCOS. To assess whether improvement in diagnosis and management after the educational 
session occurred, a chart review to assess ordering of appropriate laboratory testing for diagnosis 
and metabolic screening for development of a management plan was conducted. Currently, 
whether the provider orders a diagnostic evaluation for women who present with symptoms 
suggesting PCOS remains dependent on the provider‟s knowledge. 
The second question posed was “Are the appropriate metabolic screens being ordered?” 
The response was either yes or no. A yes response at either pre or post educational session was 
selected if the provider ordered a lipid panel, and a fasting glucose or hemoglobin A1C at either 
that visit, at the flowing visit, or if those tests had been ordered within the year.  Prior to the 
educational session 64.5 % of the patients had both glucose and lipid levels evaluated and after 
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the educational session 82.6 % had this evaluation completed. No statistical difference for 
frequency of metabolic laboratory testing was found between the pre and post educational 
session.  Lack of a significant difference between screening for a metabolic disease before and 
after the educational session was expected because 12 cases prior to the educational session had 
co-morbid conditions that also require glucose and lipid level monitoring.  
 As a result of this project the primary care providers are more aware of associating the 
combination of abnormal menstrual patterns and symptoms of excess androgens with the 
underlying cause of PCOS. Thus a more holistic approach to PCOS management can occur 
instead of treating the symptoms only. The holistic approach fosters the delay or prevention of 
the long term health problems that are part of the disease process.   
 Selection of hirsutism has been added to the general e-template and the provider no 
longer is required to type this in the chart. By having the selection of “hirsutism”, each time a 
provider charts it acts as a prompt and increases their awareness that abnormal hair patterns in 
women are an indicator of an endocrine disorder that must be investigated. The results of this 
project support that education improves provider knowledge. The data does not support that the 
HealtheWV electronic charting system improves the quality of health care given to PCOS 
population at this clinic.  Further long term studies are required to assess whether health 
outcomes for women with PCOS improve as a result of electronic charting. 
Recommendations 
Technology and the use of electronic patient records is now a necessary part of most 
health systems. Technology can be a helpful tool for providers that can improve health care 
delivery. As electronic systems improve with advancing technology, nurses need to be involved 
with the design. Nurses can bring evidence- based care recommendations for patient care plans 
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into charting systems. Nurses can provide knowledge about, not only the disease but also the 
function of the health care system to technicians who design the systems, so that electronic 
charting systems become easier to use and are helpful to providers caring for chronically ill 
patients including women with PCOS. A user friendly system is more likely to be utilized by 
providers to the fullest capacity for which the technology is designed. Providers will more 
readily rely on an evidence-based, user friendly tool as an aid to keep them informed and 
proactive in the care of women with PCOS.  
Nurse practitioners and other providers who care for women must be more vigilant about 
recognizing signs and symptoms of PCOS. Nurse practitioners have the potential to develop 
national professional meetings and workshops. Such professional educational forums should be 
encouraged to include content that focuses on PCOS. Nurses who practice at the highest level 
and implement practice changes based on evidence from research should educate providers 
through workshops, publications and clinical practice as they care for women who live with 
PCOS every day. 
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Timeline 
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Timeline 
Objective Time Line 
Step 1 
·  Synthesize and organize the current science 
·  Write learning objectives for the education session 
·  Write the content of the education session 
·  Write the pre and post-test 
·  Implement the education session 
 
 
 
 
August 10, 2008 
August 10, 2008 
August 10, 2008 
August 10, 2008 
September, 2008 
Step 2 
·  Work with the technicians at HealtheWV to develop the 
management plan template 
·  Chart Review to determine percentage of PCOS plans 
that are initiated at time of diagnosis in the electronic 
system occurs 
 
 
December 15, 2008 
 
August 15, 2009 
Step 3 
·  Analyze the impact of the project by: 
1) Measuring the difference in the mean test scores on the 
       pre and post test given to providers who attend the session. 
2) Determining the percentage providers initiating the 
      electronic PCOS care plans initiated by the provider  
 
December15, 2009 
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Appendix B 
Budget 
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PCOS Capstone Project 
Proposed Budget My Cost 
Personnel   
My time   $                     0      
Secretary support   $                     0    
IT technician time (HealtheWV)   $                     0 
  
Supplies   
Paper  $10.39/ream   $              10.39  
Ink       $30.00/per cartridge   $              60.00  
  
Overhead Expense   
Telephone expense Donated by SON 
Office space Donated by SON 
Library Fee if Ind. Project HSC Fee paid 
Source of the cost of supplies is based on Office Depot web site and costs in 2008. 
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Appendix C 
Pretest-Posttest 
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Pre-Test for PCOS Provider Education Session 
 
1.  What are the three diagnostic criteria for PCOS based on the 1991 NIH Conference  
and the Androgen Excess Society in 2006?  
 
A. Polycystic ovaries, insulin resistance, clinical or lab findings of  
Hyperandrogenism 
 
B. Chronic anovulation, clinical or lab findings of  hyperandrogenism, exclusion of other 
causes of hyperandrogenism 
 
C. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, polycystic ovaries 
 
D. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, insulin resistance 
 
 
2.   All of the following are other causes of hyperandrogenemia EXCEPT: 
 
A. Cushing‟s Syndrome 
B. Non-classical congenital hyperplasia 
C. Abnormal LH:FSH ratio 
D. Acromegaly 
 
           3.  Which of the following groups are the recommended diagnostic laboratory studies to order? 
 
A. Total testosterone, 17-hydroxyprogesterone, Prolactin level, TSH 
B. Total testosterone, 17-hydroxyprogesterone, LH, FSH 
C. Total testosterone, LH, FSH, Insulin level 
E. Total testosterone, Pelvic U/S of the ovaries, Fasting blood sugar, Insulin level 
 
4.   Women with PCOS are at risk of developing the all of following EXCEPT: 
 
A. Sleep Apnea 
B. Ovarian cancer 
C. Metabolic syndrome 
D. Hyperthyroidism 
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5.    The management plan for women with PCOS should begin with: 
 
A. Lab screenings for insulin resistance and begin metformin if indicated 
B. Life-style changes  
C. Prescribe oral contraceptive to protect the uterine lining 
D. A pelvic ultrasound to look for cystic ovaries and endometrial stripe size 
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Post Test for PCOS Provider Education Session 
 
1.  What are the three diagnostic criteria for PCOS based on the 1991 NIH Conference  
and the Androgen Excess Society in 2006?  
 
A. Polycystic ovaries, insulin resistance, clinical or lab findings of  
a. Hyperandrogenism 
 
B. Chronic anovulation, clinical or lab findings of  hyperandrogenism, exclusion of other 
causes of hyperandrogenism 
 
C. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, polycystic ovaries 
 
D. Clinical or lab findings of hyperandrogenism, elevated LH:FSH ratio, insulin resistance 
 
2.   All of the following are other causes of hyperandrogenemia EXCEPT: 
 
A. Cushing‟s Syndrome 
B. Non-classical congenital hyperplasia 
C. Abnormal LH:FSH ratio 
D. Acromegaly 
 
           3.  Which of the following groups are the recommended diagnostic laboratory studies to order? 
 
A. Total testosterone, 17-hydroxyprogesterone, Prolactin level, TSH 
B. Total testosterone, 17-hydroxyprogesterone, LH, FSH 
C. Total testosterone, LH, FSH, Insulin level 
D. Total testosterone, Pelvic U/S of the ovaries, Fasting blood sugar, Insulin level 
 
4.   Women with PCOS are at risk of developing the all of following EXCEPT: 
 
A. Sleep Apnea 
B. Ovarian cancer 
C. Metabolic syndrome 
D. Hyperthyroidism 
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5.    The management plan for women with PCOS should begin with: 
 
A. Lab screenings for insulin resistance and begin metformin if indicated 
B. Life-style changes  
C. Prescribe oral contraceptive to protect the uterine lining 
D. A pelvic ultrasound to look for cystic ovaries and endometrial stripe size 
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Appendix D 
Educational Session PowerPoint Slides 
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Elizabeth DuRant, WHNP-BC, CNM
 
 
 
Purpose of Presentation
 Brief educational unit on PCOS to introduce a 
management plan that will be found as a chronic 
illness template in HealtheWV
1
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At the end of the session the participant:
 Will be able to state the diagnostic criteria for PCOS
 Identify other causes of excess androgen that must be 
excluded
 Identify initial laboratory tests for diagnosis
 Be able to name the risks associated with PCOS
3
 
 
A typical clinical presentation
 Irregular  or absent menstrual cycle 
 Episodes of prolong heavy vaginal bleeding
&
 Hirsutism and/or Acne
or
 Inability to conceive
4
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Diagnostic Criteria
NIH 1991 Conference Rotterdam Consensus 
2003 (2 of 3)
Androgen Excess Society 
(AES) 2006
Chronic anovulation Oligo-and/or anovulation Oligo or anovulation &/or  
polycystic ovaries 
Clinical signs  or androgen 
excess &/or  
Elevated Testosterone 
Levels
Clinical signs &/or  
Elevated testosterone 
Levels
Clinical signs of androgen 
excess  &/or  
Elevated Testosterone Levels
Exclusion of other causes Polycystic ovaries* Exclusion of other causes
Rotterdam Consensus 2003 also includes exclusion of other causes as part of the diagnostic criteria.
* Polycystic ovaries are defined as having at least 12 or more follicles measuring between two to 
nine millimeters in diameter or an enlarged ovarian volume of greater than 10 millimeters cubed 
(Balen, Laven, Tan, 2003).
5
 
 
Which one to follow?
 ACOG follows the NIH & AES definitions. (ACOG, 
2007).
 The Women’s Health Certificate Program, and Internal 
Medicine use the Rotterdam Criteria
6
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Differential and Similar Clinical Features
Condition Signs of excess 
androgen
Oligo or 
amenorrhea
Clinical Differential 
features
*Non-classical 
Congenital adrenal 
hyperplasia
Yes Usually but 
may have 
regular cycles
Fam Hx of infertility, 
hirsutism or both; 
Ashkenazi Jewish 
Ancestry
Cushing’s 
Syndrome
Yes Yes HTN, striae, easy 
bruising, upper body 
obesity with thin 
extremities, round 
face, thick neck
Hyper-
prolactinemia
None or Mild
(↑DHEAS)
Yes Galactorrhea
Primary 
Hypothyroidism
None or Mild May be present Goiter maybe 
present
7
 
 
Differential and Similar Clinical Features
Condition Signs of excess 
androgen
Oligo or 
amenorrhea
Clinical Differential 
features
Acromegaly None or Mild Usually Enlarged arms, 
hands, fingers, legs, 
ears w/ course 
features, 
Prognathism
Premature ovarian 
failure
None Yes Associated w/ 
autoimmune 
endocrinopathies
Simple Obesity May be Possible, not 
often
Dx of exclusion of 
other causes
Virilizing adrenal 
or ovarian 
neoplasm
Yes Yes Clitoromegaly, 
extreme hirsutism or 
male-pattern 
alopecia
Drug-related Often Possible Evidence by Hx 8
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What to order for Dx
 Total testosterone
 17-hydroxyprogesterone (17-OHP)
 Prolactin level
 Thyroid Stimulating Hormone (TSH)
9
 
 
Other potential Dx Labs
 DHEAS if testosterone is extremely elevated 
suggesting an androgen secreting adrenal tumor. 
 If 17-OHP is > 200 ng/dl then refer for an ACTH level. 
When 17-OHP > than 800 ng/dl then a diagnosis of 
CAH may be made. 
10
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Secondary Causes of Hyperandrogenism & Diagnostic Lab  
Findings
Disease Lab findings Dx values
•Pituitary Tumor 
•Adrenal tumors
•Ovarian tumors
•Non-classic CAH
•Hypercortisolism
•Elevated prolactin
•Elevated DHEA/DHEAS
•Elevated testosterone
•Elevated 17-OH progesterone
•24 hr urine collection level of 
cortisol
150 ng/ml 
700 ng/dl
150 ng/dl
800 ng/dl
 100 mcg/
24hr specimen
11
Buccola & Reynolds. (2003). Polycystic Ovarian Syndrome: a review for primary providers. Primary Care: 
Clinics in Office Practice 30(4)
 
 
 
Optional testing to consider
Ultrasound evaluation of the pelvis for 
baseline evaluation and assessment of 
sudden onset of excess androgen 
symptoms.
Gonadotrophin levels if evaluating causes 
of amenorrhea.
12
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Health Risks Associated w/ PCOS
 Metabolic disorders
1. Central obesity - waist to hip ratio > 0.72 
2. HTN
3. Dyslipidemia
4. Nonalcoholic fatty liver
5. Coronary calcifications
6. Abnormal C-reactive protein
14
 
 
 
Health Risks Associated w/ PCOS
 Reproductive System Cancers
1. Endometrial hyperplasia 
2. Endometrial cancer
3. Ovarian cancer
4. Breast cancer
 Most likely due to years of unopposed estrogen
15
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Health Risks Associated w/ PCOS
 Sleep Apnea
Despite BMI women with PCOS have a 30 fold 
increase in the incidence of sleep apnea
 Depression
 Infertility
16
 
 
 
Labs to monitor health status
 2 hr Oral Glucose Tolerance Test 
Fasting B/S often miss IR PCOS 
Optimal screening interval is not known < every 3 
years in high risk persons.
 Lipid panel - Optimal interval for screening is 
uncertain. Decisions should take into account 
overall risk of heart disease
17
 
 
                                                                                                                          PCOS Project 67 
Screenings to Detect Cancer
 Endometrial Cancer
No effective screening method
Endometrial Bx for abnormal bleeding
TV/US or trans-abdominal
US cannot Dx but can provide information to   
aid in Dx
18
 
 
 
Screenings to Detect Cancer
 Ovarian Cancer
No effective screening method
Maintain a high degree of suspicion and monitor 
for Sx (bloating, early satiety, sudden abd. girth 
increase)
 Breast Cancer
Annual CBE
Mammography* every 1-2 yrs beginning at age 40 
or with abnormal CBE findings
*BCCSP – Age 50
19
 
 
                                                                                                                          PCOS Project 68 
Management of PCOS
 Early recognition can delay or prevent complications
 Depends on the presenting signs and symptoms
 Lifestyle modification is 1st line treatment
20
 
 
 
Management of PCOS
 Hirsutism & Acne – COCP, 
Spironolactone, Mechanical hair removal
 Treat the unopposed estrogen state with an OCP or 
DMPA. Yaz® is the OCP of first choice. If not 
available select a pill w/ low or nonandrogenic 
progesterone effects.
21
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Management of PCOS
 Abnormal Menstrual Pattern –
1. Cyclic progesterone or COCP
2. Without hormone therapy - regular   
ultrasound to monitor endometrial
thickness
22
 
 
 
Management of PCOS
 Screen for signs of metabolic syndrome – Metformin?
 Screen for and order a sleep study if symptoms 
indicate a need.
 Screen for depression at each visit
23
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Follow Up
 Depends on individual signs, symptoms, & treatment 
plan
 Every 6 months for abnormal B/P, fasting glucose, and 
lipids 
 Every 3-6 months initially for anti-androgen therapy
 Yearly CBE, pelvic exam and mammogram if indicated.
24
 
 
 
HEALTHeWV
 Following the other HeatheWV electronic chronic 
care models, a model for the management is being 
developed and will be available.
 ? Questions ?
25
 
 
                                                                                                                          PCOS Project 71 
With Women for a Lifetime
Thank YOU
For listening
26
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Appendix E 
Table 1 Test Scores from Educational Session 
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Table 1 Test Scores from Educational Session 
 
 Pretest       Post test 
 N 
Mean 
Minimum 
Maximum 
10 
1.50 
0 
3 
      8 
      4.25 
      3 
      5 
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Appendix F 
Table 2 Educational Session Test Statistics 
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Table 2 Educational Session Test Statistics 
 
Mann-Whitney U 
Wilcoxon W 
Z 
Asymp.Sig. (2-tailed) 
Exact Sig, {2* (1-tailed Sig,)] 
.500 
55.500 
-3.579 
.000 
.000 
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Appendix G 
Figure 1 Questions Answered Correctly 
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                                             Figure 1 Questions answered correctly 
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Appendix H 
PCOS Template 
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Appendix I 
Table 3 Appropriate Diagnostic Testing 
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Table 3 Appropriate Diagnostic Testing 
                                     N                        Percent  
Pre Education Cases with 
Appropriate Diagnostic Labs  
 
Post Education Cases with 
Appropriate Diagnostic Labs 
10 of 31 
 
 
16 of  23 
32.3 
 
 
69.6 
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Appendix J 
Figure 2 Percentage of Appropriate Diagnostic Laboratory Tests Ordered 
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Figure 2 Percentage of Appropriate Diagnostic Laboratory Tests Ordered  
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Appendix K 
Table 4 Appropriate Metabolic Screening Tests 
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Table 4 Appropriate Metabolic Screening Tests 
                                                                              N                                   Percent 
Pre Education Cases with 
Appropriate Metabolic Screenings  
 
Post Education Cases with 
Appropriate Metabolic Screenings 
20 of 31 
 
 
19 of  23 
64.5 
 
 
82.6 
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Appendix L 
Figure 3 Appropriate Metabolic Screening Tests 
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Figure 3 Appropriate Metabolic Screening Tests 
 
 
 
 
Metabolic Screening Tests
64.5
82.6
0
20
40
60
80
100
1
Pre Education 
Post Education
